Z167 PHOSPHATIDYLSERINE ANTIBODIES PANEL, IgG & IgM
S120 PHOSPHATIDYLSERINE ANTIBODY, IgG
S121 PHOSPHATIDYLSERINE ANTIBODY, IgM
S255 PHOSPHOLIPASE A2 RECEPTOR ANTIBODY (PLA2R), QUANTITATIVE
S240 PHOSPHOLIPASE A2 RECEPTOR ANTIBODY (PLA2R)
Z287 PHOSPHOLIPID ANTIBODIES PANEL, IgG & IgM
Z854 PHOSPHOLIPID SYNDROME PANEL WITH BETA 2 GLYCOPROTEIN 1, IHR
S257 PLACENTAL GROWTH FACTOR (PLGF)
OS178 PLASMINOGEN ACTIVATOR INHIBITOR-1/SERPINE-1, 4G/5G GENOTYPING
H251 PLATELET COUNT, FLUORESCENT (PLT-F)
H210 PLATELET DISTRIBUTION WIDTH; PDW
N038 PML RARA t(15;17)(q22;q12) GENE REARRANGEMENT QUALITATIVE, PCR
N152 PML RARA T(15;17)(Q22;Q12) GENE REARRANGEMENT QUANTITATIVE, MRD MONITOR
N095 PML RARA T(15;17)(Q22;Q12) GENE REARRANGEMENT QUANTITATIVE, PCR
Z662B PML-RARA GENE REARRANGEMENT, QUALITATIVE, PCR
P097 POLARIZING MICROSCOPY, BODY FLUIDS
G128 POMPE DISEASE, QUANTITATIVE, BLOOD
U029 PORPHOBILINOGEN (PBG), QUALITATIVE, URINE
U098 PORPHOBILINOGEN (PBG), QUANTITATIVE, 24 HOUR URINE
U053 PORPHYRINS TOTAL, QUALITATIVE, RANDOM URINE
U003 PORPHYRINS TOTAL, QUANTITATIVE, 24- HOUR URINE
OS179 PRADER-WILLI SYNDROME MUTATION DETECTION, METHYLATION SPECIFIC PCR
Z841 PRE-ECLAMPSIA PREDICTION PANEL (PLGF, SFLT, SFLT-1/PLGF RATIO)
S258 PREGNANCY ASSOCIATED PLASMA PROTEIN A (PAPP-A), SERUM
N157 PREIMPLANTATION GENETIC SCREENING (PGS)
XX053 PRENATAL COMPREHENSIVE SCREENING PANEL 1
Y561 PRENATAL DIAGNOSIS, FABRY DISEASE
Y559 PRENATAL DIAGNOSIS, GAUCHER DISEASE
Y557 PRENATAL DIAGNOSIS, GM1 GANGLIOSIDOSIS
Y558 PRENATAL DIAGNOSIS, GM2 GANGLIOSIDOSIS